[Venous vascular malformations and their treatment with Ethibloc].
The use of Ethibloc must be contemplated as a first-intention treatment for venous malformations of the face. This sclerosing agent has transformed the functional, esthetic and psychological prognosis for these vascular malformations.
Herbreteau
D
D
Groupe pluridisciplinaire des malformations vasculaires, Hôpital Lariboisière, Paris.
Riche
M C
MC
Enjolras
O
O
Lemarchand
F
F
Laurian
C
C
Brette
M D
MD
Merland
J J
JJ
D001165:Arteriovenous Malformations / Q000628:therapy*; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic / Q000379:methods*; D005145:Face / Q000098:blood supply*; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins / Q000627:therapeutic use*; D014680:Veins / Q000002:abnormalities; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution
Les malformations vasculaires veineuses et leur traitement par Ethibloc.